Using music to help young children with leukemia and their parents cope with treatment stress
Biologic Mechanisms and Dosing of Active Music Engagement to Manage Acute Treatment Distress and Improve Health Outcomes in Young Children with Acute Lymphoblastic Leukemia and Parents
This study is looking at how making music can help young children with leukemia and their parents feel better emotionally and physically during treatment, and it aims to show how music therapy can improve their overall well-being.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-10878989 on NIH RePORTER |
What this research studies
This research investigates how active music engagement can help manage the emotional and biological stress experienced by young children with acute lymphoblastic leukemia and their parents during treatment. The study involves a randomized controlled trial that examines the effects of music therapy on both psychosocial and biological outcomes, including immune function. By exploring the dose-response relationship of music therapy, the research aims to provide a deeper understanding of how music can alleviate distress and improve quality of life for families facing cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are young children aged 3-8 years diagnosed with acute lymphoblastic leukemia and their parents or caregivers.
Not a fit: Patients who are not diagnosed with acute lymphoblastic leukemia or are outside the age range of 3-8 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance the emotional well-being and immune health of young children undergoing cancer treatment and their caregivers.
How similar studies have performed: Previous research has shown promising results for music therapy in improving psychosocial outcomes in pediatric cancer care, but this study aims to explore its biological effects, making it a novel approach.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Robb, Sheri L — Indiana University Indianapolis
- Study coordinator: Robb, Sheri L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.